About CoJourney
CoJourney is a company based in Ambler (United States) founded in 2021. It operates as a Managed Services and HealthTech. CoJourney has raised $30 million across 1 funding round from investors including Legend Holdings, GL Ventures and Legend Star. CoJourney offers products and services including Zero Chrom Plasmid Platform, Viral Vectors Manufacturing, sgRNA GMP Manufacturing, Exosome Manufacturing, and Analytical Services. CoJourney operates in a competitive market with competitors including Blue Rock Therapeutics, CellCarta, Impel Pharmaceuticals, Ascend and RiboPro, among others.
- Headquarter Ambler, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Cojourney Inc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$30 M (USD)
in 1 rounds
-
Latest Funding Round
$30 M (USD), Series A
Jul 11, 2023
-
Investors
Legend Holdings
& 3 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of CoJourney
CoJourney offers a comprehensive portfolio of products and services, including Zero Chrom Plasmid Platform, Viral Vectors Manufacturing, sgRNA GMP Manufacturing, Exosome Manufacturing, and Analytical Services.
High-purity plasmids are produced for gene therapy applications.
High-yield viral vectors are manufactured for therapeutic use.
Optimized sgRNA is produced for accurate gene editing.
Exosomes are manufactured for innovative therapeutic development programs.
Assay development and testing services are provided comprehensively.
Funding Insights of CoJourney
CoJourney has successfully raised a total of $30M through 1 strategic funding round. The most recent funding activity was a Series A round of $30 million completed in July 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in CoJourney
CoJourney has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include Legend Holdings, GL Ventures and Legend Star.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Chinese startups are funded and incubated by Legend Star.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
Investment holding company
|
Locked | Locked | Locked |
Investor details for CoJourney
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by CoJourney
Investment portfolio details for CoJourney
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - CoJourney
Detailed financials for CoJourney
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Cojourney Comparisons
Peer comparison for CoJourney
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of CoJourney
CoJourney operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Blue Rock Therapeutics, CellCarta, Impel Pharmaceuticals, Ascend and RiboPro, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Stem cell therapies are developed for cardiovascular and neurological diseases.
|
|
| Locked | Locked | Locked |
Histopathology and genomics services are offered by the CRO.
|
|
| Locked | Locked | Locked |
Transformative therapies are developed and commercialized through specialized services.
|
|
| Locked | Locked | Locked |
Online insurance payments and premium financing are enabled for businesses.
|
|
| Locked | Locked | Locked |
Online supplier and developer of RNA based products
|
|
| Locked | Locked | Locked |
Stem cell drug research and clinical trial services are provided.
|
Detailed competitors of CoJourney
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Cojourney
Complete news archive for CoJourney
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about CoJourney
CoJourney was founded in 2021 and raised its 1st funding round 2 years after it was founded.
CoJourney is headquartered in Ambler, United States. It is registered at Ambler, Pennsylvania, United States.
Lijun Wang is the current CEO of CoJourney.
CoJourney is a funded company, having raised a total of $30M across 1 funding round to date.
CoJourney is involved in providing end-to-end process development and cGMP manufacturing solutions for gene therapy applications. The company specializes in high-yield, high-purity production of plasmids, viral vectors, sgRNA, and exosomes through innovative platforms like Zero Chrom. Services are tailored to support both clinical and commercial applications across the biotechnology sector. Regulatory compliance with FDA, EMA, and NMPA standards is ensured through state-of-the-art facilities and robust quality systems. Cost and environmental benefits are delivered via unique manufacturing processes and facility designs.
CoJourney's top competitors include Blue Rock Therapeutics, Ascend and CellCarta.
CoJourney offers Zero Chrom Plasmid Platform, Viral Vectors Manufacturing, sgRNA GMP Manufacturing, Exosome Manufacturing, and Analytical Services.
CoJourney has 4 investors. Key investors include Legend Holdings, GL Ventures, Legend Star, and Lake Bleu Capital.